Your daily horoscope: May 28, 2025
Intense cosmic activity in the area of your chart that governs travel and social activities means you will be even more friendly and outgoing than usual today. Avoid people whose outlook on life is defined by negativity – they are a drain on your energy.
The sun, Mercury and Jupiter in the money area of your chart makes this a good time to look at your financial situation and start making plans for a richer and more enjoyable future. Think lucky and you will be lucky, it's really that simple.
After being on such an emotional high over the past few days it follows that you could feel a bit down over the next 24 hours, but it is only a temporary blip in your surge to the top. Overall you are still on an upward trajectory.
You don't have to conform to other people's expectations and be the life and soul of the party. You have a great deal on your mind at the moment, so you cannot afford to waste time and energy on people who don't know how to be serious.
All things are possible for you now and if you can believe that with both your head and your heart the events of the next few days will seem nothing less than miraculous. To start with, a new friendship will inspire you to reach for the stars.
When you want something enough no one and nothing is able to stop you, and because you desire to move up in the world all your efforts must now be focused on your career. Powerful people will admire your ambition, and maybe fear it a bit as well.
If you can visualize what it is you are trying to accomplish there is no doubt at all that it will soon be a reality. The more you can focus your thoughts on a single ambition the more likely it is your dream result will take shape.
Do you have what it takes to compete at the highest level? Of course you do! Make it your business between now and the weekend to act as if the fruits of success are already coming your way. As you think, so it will be.
You will have to deal with someone today who is every bit as ambitious as you are and the potential for conflict is clear. However, if you can put aside your competitive instincts for a bit you can find ways to work together that benefit you both.
If you approach a task you don't have much enthusiasm for in a positive frame of mind it may turn out to be an enjoyable experience. What you do matters less than the manner in which you choose to do it, so choose energy and excellence.
You may not care much for rewards and applause but you are going to get plenty of both over the next few days. How long you remain in the spotlight will depend on how well you handle yourself while every eye in the house is on you.
The more advice you get from family and friends and colleagues today the more inclined you will be to ignore it and that's a good thing. As one of the zodiac's most intuitive signs you know you can trust what your inner voice tells you.
Discover more about yourself at sallybrompton.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians
Shaping the Future of Medicine: Dr. Guy Navarra Launches Scholarship for Aspiring Physicians Newburyport, Massachusetts - Undergraduate students with dreams of becoming doctors now have a new opportunity to jumpstart their journey, thanks to the launch of the Dr. Guy Navarra Scholarship for Future Doctors. This $1,000 scholarship recognizes and supports one outstanding student preparing to enter the medical field—someone whose vision, heart, and dedication echo the values of its founder, Dr. Guy Navarra. The scholarship, now accepting applications, is designed for U.S.-based undergraduate students pursuing careers in medicine, pre-medical studies, or related health sciences. With the growing need for committed, forward-thinking professionals in healthcare, Dr. Guy Navarra aims to reward a student who not only excels academically but also holds a strong purpose for making an impact in tomorrow's healthcare system. To apply, students must submit a personal essay (500–800 words) in response to the following prompt: 'What inspires your journey into medicine, and how do you envision making a meaningful impact on the healthcare system of tomorrow?' Essays will be judged on clarity, authenticity, creativity, and alignment with the mission of Dr. Navarra's scholarship: to cultivate leadership, empathy, and transformation in the next generation of doctors. Dr. Guy Navarra brings a wealth of knowledge and inspiration to this initiative. With over 25 years of experience in internal medicine, geriatrics, and obesity medicine, he has held roles in clinical care, academic research, hospital leadership, and executive strategy. A graduate of Madrid's Complutense University, and later Yale and Harvard, Dr. Guy Navarra exemplifies what it means to blend global education with patient-centered care. His commitment to preventative medicine and ethical innovation has shaped programs, improved lives, and helped bridge gaps in the healthcare system. Currently serving as primary care physician for the Greater Newburyport area and Chief Medical Officer for MetTrimMD, Dr. Guy Navarra continues to lead by example—pioneering patient-first approaches to metabolic health and chronic disease management. Through this scholarship, he now turns his focus to supporting students who are following in his footsteps. 'The future of medicine depends not just on knowledge, but on heart and vision,' says Dr. Guy Navarra. 'This scholarship is a way to honor students who are already showing signs of leadership, passion, and the ability to think critically about where healthcare is headed.' Interested students should email their essay submission along with basic academic details—name, major, university, expected graduation year, and a short bio—to apply@ The deadline to apply is April 15, 2026, and the scholarship recipient will be publicly announced on May 15, 2026. The $1,000 award can be applied toward tuition, educational supplies, or other school-related expenses. It's not just a financial boost—it's a mark of recognition from a physician who believes deeply in mentoring the leaders of tomorrow. To learn more, visit the official scholarship site at Media Contact Company Name: Dr. Guy Navarra Scholarship Contact Person: Dr. Guy Navarra Email: Send Email City: Newburyport State: Massachusetts Country: United States Website:
Globe and Mail
an hour ago
- Globe and Mail
Dr. Konstantinos Zarkadas Scholarship for Future Doctors Announces National Call for Applications from Aspiring Medical Students
Glen Cove, New York - The Dr. Konstantinos Zarkadas Scholarship for Future Doctors is now accepting applications from undergraduate students across the United States who demonstrate academic excellence, leadership, and a clear commitment to pursuing a career in medicine. This prestigious initiative, founded by Dr. Konstantinos Zarkadas, aims to support and recognize the next generation of medical professionals preparing to address the evolving challenges of 21st-century healthcare. The scholarship reflects Dr. Konstantinos Zarkadas's longstanding commitment to education, innovation, and improving healthcare access. A respected leader in the medical community, Dr. Konstantinos Zarkadas serves as the Chief Medical Officer of Arch Sleep Apnea Solutions and has previously owned and operated multiple successful practices throughout New York. His professional journey spans from a psychology degree at Hunter College to medical training in the Dominican Republic, and a Master of Health Administration from Columbia University's Mailman School of Public Health. Fluent in English, Greek, and Spanish, Dr. Konstantinos Zarkadas is known for delivering quality care to diverse communities and is passionate about guiding future physicians to do the same. The Dr. Konstantinos Zarkadas Scholarship for Future Doctors is open to undergraduate students currently enrolled at accredited U.S. colleges or universities who are pursuing a pre-medical track or related major. Eligible applicants must maintain a minimum 3.5 GPA, be a U.S. citizen or permanent resident, and exhibit strong leadership and community involvement. To apply, students must submit: 'Healthcare faces numerous challenges in the 21st century, from advancing technology to serving diverse populations. Drawing from your personal experiences and aspirations, describe a significant healthcare challenge you hope to address as a future physician and how your unique perspective will contribute to solving it. Include specific examples of how your background, experiences, or goals have prepared you to make this impact.' Applicants must also provide their full name, contact information, high school and graduation date, current university name, GPA, and a personal bio. All materials should be submitted by email to apply@ no later than November 15, 2025. Applications will be reviewed by a committee of healthcare professionals and educators, with selected finalists contacted for virtual interviews. The winning recipient will be announced on December 15, 2025, and the scholarship will be disbursed directly to the student's educational institution. Dr. Konstantinos Zarkadas believes deeply in the power of education and mentorship to shape the future of healthcare. This scholarship serves as an extension of that vision—supporting driven students who are ready to lead with compassion, critical thinking, and a global perspective. For more information and application details, please visit: Media Contact Company Name: Dr. Konstantinos Zarkadas Scholarship for Future Doctors Contact Person: Dr. Konstantinos Zarkadas Email: Send Email City: Glen Cove State: New York Country: United States Website:
Globe and Mail
2 hours ago
- Globe and Mail
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Our mission remains steadfast: delivering clinically impactful, economically accessible therapies by leveraging cutting-edge science and technology. Tevogen has become a recognized name for its business philosophy of social responsibility, patient affordability and cost efficiency. In under five years, we validated our proprietary ExacTcell™ platform, completed successful proof-of-concept clinical trial of the platforms first product, established drug discovery R&D center — currently in the process of establishing our own GMP cell manufacturing facility, expanded corporate infrastructure, built a robust intellectual property portfolio, and established one of the pioneering AI initiatives in the industry — assets of significant value, while maintaining 74% insider equity ownership. With the successful launch of our proprietary AI-driven PredicTcell™ platform, we've significantly enhanced target discovery efficiency. Strategic partnerships with global technology leaders, such as Microsoft and Databricks, have accelerated our progress. Recent patent filings further secure our intellectual property in AI-driven predictive modeling, positioning us at the forefront of innovation. Importantly, Tevogen Bio is well capitalized, having access to necessary funding we may require to fully execute our current growth strategy, including the accelerated development of While the sector faces significant challenges, our company continues to grow, underscoring the foundational strength of our company. We deeply appreciate your continued support as we work toward our vision of transforming healthcare through democratizing access. It feels good to be part of this growth story and am grateful to my colleagues at Tevogen for their exceptional expertise, dedication, and, above all, their compassion for others. Sincerely, Ryan Saadi, MD, MPH Founder and CEO, Tevogen Bio Recent Announcements Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility Builds Alpha Version of PredicTcell Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation Forward-Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts
